Glucocorticoid-induced osteoporosis: presentation and comments on the new American College of Rheumatology guidelines
The article presents a review of the clinical guidelines of 2017 American College of Rheumatology for prevention and treatment of glucocorticoid-induced osteoporosis. The guidelines i contain fracture risk gradation not only for people over 40 years , based on the measurement of bone mineral density...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2018-04-01
|
Series: | Остеопороз и остеопатии |
Subjects: | |
Online Access: | https://osteo-endojournals.ru/osteo/article/viewFile/9593/7199 |
id |
doaj-1391861d09ad4653a940b705b1b93c95 |
---|---|
record_format |
Article |
spelling |
doaj-1391861d09ad4653a940b705b1b93c952021-07-02T21:14:58ZengEndocrinology Research CentreОстеопороз и остеопатии2072-26802311-07162018-04-0120311412010.14341/osteo20173114-1208452Glucocorticoid-induced osteoporosis: presentation and comments on the new American College of Rheumatology guidelinesNatalia V. Toroptsova0Research Institute of Rheumatology named after V.A. NasonovaThe article presents a review of the clinical guidelines of 2017 American College of Rheumatology for prevention and treatment of glucocorticoid-induced osteoporosis. The guidelines i contain fracture risk gradation not only for people over 40 years , based on the measurement of bone mineral density, 10-year probability of fractures by FRAX and prior osteoporotic fractures, but also for people under 40 years. The guidelines present , recommendations for initial and follow-up treatment for prevention of glucocorticoid-induced osteoporosis according the level of risk of fractures in different age groups of adults, and in children from 4 years of age, in patients with organ transplant and patients older than 30 years, receiving very high-dose of glucocorticoids . Oral bisphosphonates were recommended as first line treatment due to safety, cost, and because of lack of evidence for superior antifracture benefits from other OP medications. Oral bisohosphonates could be switched to another medication in case of intolerance. The issues of applicability of these recommendations in national clinical practice are being discussed.https://osteo-endojournals.ru/osteo/article/viewFile/9593/7199osteoporosisglucocorticoidfracturepractice guidelinecomment |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Natalia V. Toroptsova |
spellingShingle |
Natalia V. Toroptsova Glucocorticoid-induced osteoporosis: presentation and comments on the new American College of Rheumatology guidelines Остеопороз и остеопатии osteoporosis glucocorticoid fracture practice guideline comment |
author_facet |
Natalia V. Toroptsova |
author_sort |
Natalia V. Toroptsova |
title |
Glucocorticoid-induced osteoporosis: presentation and comments on the new American College of Rheumatology guidelines |
title_short |
Glucocorticoid-induced osteoporosis: presentation and comments on the new American College of Rheumatology guidelines |
title_full |
Glucocorticoid-induced osteoporosis: presentation and comments on the new American College of Rheumatology guidelines |
title_fullStr |
Glucocorticoid-induced osteoporosis: presentation and comments on the new American College of Rheumatology guidelines |
title_full_unstemmed |
Glucocorticoid-induced osteoporosis: presentation and comments on the new American College of Rheumatology guidelines |
title_sort |
glucocorticoid-induced osteoporosis: presentation and comments on the new american college of rheumatology guidelines |
publisher |
Endocrinology Research Centre |
series |
Остеопороз и остеопатии |
issn |
2072-2680 2311-0716 |
publishDate |
2018-04-01 |
description |
The article presents a review of the clinical guidelines of 2017 American College of Rheumatology for prevention and treatment of glucocorticoid-induced osteoporosis. The guidelines i contain fracture risk gradation not only for people over 40 years , based on the measurement of bone mineral density, 10-year probability of fractures by FRAX and prior osteoporotic fractures, but also for people under 40 years. The guidelines present , recommendations for initial and follow-up treatment for prevention of glucocorticoid-induced osteoporosis according the level of risk of fractures in different age groups of adults, and in children from 4 years of age, in patients with organ transplant and patients older than 30 years, receiving very high-dose of glucocorticoids . Oral bisphosphonates were recommended as first line treatment due to safety, cost, and because of lack of evidence for superior antifracture benefits from other OP medications. Oral bisohosphonates could be switched to another medication in case of intolerance. The issues of applicability of these recommendations in national clinical practice are being discussed. |
topic |
osteoporosis glucocorticoid fracture practice guideline comment |
url |
https://osteo-endojournals.ru/osteo/article/viewFile/9593/7199 |
work_keys_str_mv |
AT nataliavtoroptsova glucocorticoidinducedosteoporosispresentationandcommentsonthenewamericancollegeofrheumatologyguidelines |
_version_ |
1721322239405588480 |